Oncology & Cancer

The role of fibronectin in BRAF-mutant thyroid cancer treatment

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...

Oncology & Cancer

Understanding how aggressive thyroid cancer evolves

Northwestern Medicine scientists have shed new light on how the deadliest form of thyroid cancer transforms from slow-growing to aggressive, according to research published in the Journal of Clinical Investigation.

page 3 from 24